Andros Pharmaceuticals Co., Ltd.

Andros Pharmaceuticals Co., Ltd. is a biopharmaceutical company specializing in the research, development, and manufacture of novel drug delivery systems, with a particular focus on formulations related to topical medications and pain management. Established in 2008 and headquartered in Zhubei, Taiwan, the company leverages proprietary drug delivery technologies and a strong R&D team to create innovative dosage forms addressing unmet medical needs in anesthesia, analgesia, gene therapy, and dermatological care. Its pipeline includes products in various clinical stages, such as APC101 for post-herpetic neuralgia and APC201 for osteoarthritis pain, alongside preclinical candidates targeting anesthesia for catheter placement and post-surgical pain. In addition to its pharmaceutical innovations, Andros offers niche generic drugs and advanced skincare products, including LALP Cream for minor skin surgery anesthesia and iMinos Solution for the treatment of androgenetic alopecia. By integrating patented technologies, GMP-compliant manufacturing, and a focus on global demand, Andros Pharmaceuticals plays a dynamic role in advancing both pharmaceutical and cosmeceutical solutions in its target markets.